Global Veterinary Vaccines Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Veterinary Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 8925.5 million by 2025, from USD 6886.4 million in 2019.
The Veterinary Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Veterinary Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Veterinary Vaccines market has been segmented into:
Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
By Application, Veterinary Vaccines has been segmented into:
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Veterinary Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Veterinary Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Veterinary Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Veterinary Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Veterinary Vaccines Market Share Analysis
Veterinary Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Veterinary Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Veterinary Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Veterinary Vaccines are:
Elanco
ARKO Labs
Zoetis
Merck
Aratana Therapeutics
Merial
CanFel Therapeutics
AmpliPhi Biosciences
Advaxis
Bayer
Hygieia Biological Laboratories
Nuovo Biologics
Ceva Animal Health
Valneva
ImmuCell
Genus
Colorado Serum
UBI
Nexvet
Epitopix
Vetoquinol
Virbac
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Veterinary Vaccines Market Overview
1.1 Product Overview and Scope of Veterinary Vaccines
1.2 Classification of Veterinary Vaccines by Type
1.2.1 Global Veterinary Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Veterinary Vaccines Revenue Market Share by Type in 2019
1.2.3 Inactivated Vaccines
1.2.4 Live Attenuated Vaccines
1.2.5 Conjugate Vaccines
1.2.6 Toxoid Vaccines
1.2.7 Recombinant Vaccines
1.2.8 DNA Vaccines
1.3 Global Veterinary Vaccines Market by Application
1.3.1 Overview: Global Veterinary Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.4 Global Veterinary Vaccines Market by Regions
1.4.1 Global Veterinary Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Veterinary Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Veterinary Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Veterinary Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Veterinary Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Veterinary Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Veterinary Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Elanco
2.1.1 Elanco Details
2.1.2 Elanco Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Elanco SWOT Analysis
2.1.4 Elanco Product and Services
2.1.5 Elanco Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 ARKO Labs
2.2.1 ARKO Labs Details
2.2.2 ARKO Labs Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ARKO Labs SWOT Analysis
2.2.4 ARKO Labs Product and Services
2.2.5 ARKO Labs Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Zoetis SWOT Analysis
2.3.4 Zoetis Product and Services
2.3.5 Zoetis Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aratana Therapeutics
2.5.1 Aratana Therapeutics Details
2.5.2 Aratana Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aratana Therapeutics SWOT Analysis
2.5.4 Aratana Therapeutics Product and Services
2.5.5 Aratana Therapeutics Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merial
2.6.1 Merial Details
2.6.2 Merial Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merial SWOT Analysis
2.6.4 Merial Product and Services
2.6.5 Merial Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 CanFel Therapeutics
2.7.1 CanFel Therapeutics Details
2.7.2 CanFel Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CanFel Therapeutics SWOT Analysis
2.7.4 CanFel Therapeutics Product and Services
2.7.5 CanFel Therapeutics Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 AmpliPhi Biosciences
2.8.1 AmpliPhi Biosciences Details
2.8.2 AmpliPhi Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AmpliPhi Biosciences SWOT Analysis
2.8.4 AmpliPhi Biosciences Product and Services
2.8.5 AmpliPhi Biosciences Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 Advaxis
2.9.1 Advaxis Details
2.9.2 Advaxis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Advaxis SWOT Analysis
2.9.4 Advaxis Product and Services
2.9.5 Advaxis Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hygieia Biological Laboratories
2.11.1 Hygieia Biological Laboratories Details
2.11.2 Hygieia Biological Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hygieia Biological Laboratories SWOT Analysis
2.11.4 Hygieia Biological Laboratories Product and Services
2.11.5 Hygieia Biological Laboratories Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.12 Nuovo Biologics
2.12.1 Nuovo Biologics Details
2.12.2 Nuovo Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Nuovo Biologics SWOT Analysis
2.12.4 Nuovo Biologics Product and Services
2.12.5 Nuovo Biologics Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ceva Animal Health
2.13.1 Ceva Animal Health Details
2.13.2 Ceva Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ceva Animal Health SWOT Analysis
2.13.4 Ceva Animal Health Product and Services
2.13.5 Ceva Animal Health Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.14 Valneva
2.14.1 Valneva Details
2.14.2 Valneva Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Valneva SWOT Analysis
2.14.4 Valneva Product and Services
2.14.5 Valneva Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.15 ImmuCell
2.15.1 ImmuCell Details
2.15.2 ImmuCell Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 ImmuCell SWOT Analysis
2.15.4 ImmuCell Product and Services
2.15.5 ImmuCell Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.16 Genus
2.16.1 Genus Details
2.16.2 Genus Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Genus SWOT Analysis
2.16.4 Genus Product and Services
2.16.5 Genus Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.17 Colorado Serum
2.17.1 Colorado Serum Details
2.17.2 Colorado Serum Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Colorado Serum SWOT Analysis
2.17.4 Colorado Serum Product and Services
2.17.5 Colorado Serum Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.18 UBI
2.18.1 UBI Details
2.18.2 UBI Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 UBI SWOT Analysis
2.18.4 UBI Product and Services
2.18.3 UBI Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.19 Nexvet
2.19.1 Nexvet Details
2.19.2 Nexvet Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Nexvet SWOT Analysis
2.19.4 Nexvet Product and Services
2.19.5 Nexvet Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.20 Epitopix
2.20.1 Epitopix Details
2.20.2 Epitopix Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Epitopix SWOT Analysis
2.20.4 Epitopix Product and Services
2.20.5 Epitopix Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.21 Vetoquinol
2.21.1 Vetoquinol Details
2.21.2 Vetoquinol Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Vetoquinol SWOT Analysis
2.21.4 Vetoquinol Product and Services
2.21.5 Vetoquinol Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.22 Virbac
2.22.1 Virbac Details
2.22.2 Virbac Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Virbac SWOT Analysis
2.22.4 Virbac Product and Services
2.22.5 Virbac Veterinary Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Veterinary Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Veterinary Vaccines Players Market Share
3.2.2 Top 10 Veterinary Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Veterinary Vaccines Revenue and Market Share by Regions
4.2 North America Veterinary Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Veterinary Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Veterinary Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Veterinary Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Veterinary Vaccines Revenue and Growth Rate (2015-2020)
5 North America Veterinary Vaccines Revenue by Countries
5.1 North America Veterinary Vaccines Revenue by Countries (2015-2020)
5.2 USA Veterinary Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Veterinary Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Veterinary Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Veterinary Vaccines Revenue by Countries
6.1 Europe Veterinary Vaccines Revenue by Countries (2015-2020)
6.2 Germany Veterinary Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Veterinary Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Veterinary Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Veterinary Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Veterinary Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Veterinary Vaccines Revenue by Countries
7.1 Asia-Pacific Veterinary Vaccines Revenue by Countries (2015-2020)
7.2 China Veterinary Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Veterinary Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Veterinary Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Veterinary Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Veterinary Vaccines Revenue and Growth Rate (2015-2020)
8 South America Veterinary Vaccines Revenue by Countries
8.1 South America Veterinary Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Veterinary Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Veterinary Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Veterinary Vaccines by Countries
9.1 Middle East & Africa Veterinary Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Veterinary Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Veterinary Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Veterinary Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Veterinary Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Veterinary Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Veterinary Vaccines Market Forecast by Type (2019-2024)
10.3 Inactivated Vaccines Revenue Growth Rate (2015-2025)
10.4 Live Attenuated Vaccines Revenue Growth Rate (2015-2025)
10.5 Conjugate Vaccines Revenue Growth Rate (2015-2025)
10.6 Toxoid Vaccines Revenue Growth Rate (2015-2025)
10.7 Recombinant Vaccines Revenue Growth Rate (2015-2025)
10.8 DNA Vaccines Revenue Growth Rate (2015-2025)
11 Global Veterinary Vaccines Market Segment by Application
11.1 Global Veterinary Vaccines Revenue Market Share by Application (2015-2020)
11.2 Veterinary Vaccines Market Forecast by Application (2019-2024)
11.3 Veterinary Clinic Revenue Growth (2015-2020)
11.4 Veterinary Hospital Revenue Growth (2015-2020)
11.5 Veterinary Research Institute Revenue Growth (2015-2020)
11.6 Retail Pharmacy Revenue Growth (2015-2020)
12 Global Veterinary Vaccines Market Size Forecast (2021-2025)
12.1 Global Veterinary Vaccines Market Size Forecast (2021-2025)
12.2 Global Veterinary Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Veterinary Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Veterinary Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Veterinary Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Veterinary Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Veterinary Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Veterinary Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Veterinary Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Veterinary Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Veterinary Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Elanco Corporate Information, Location and Competitors
Table 6. Elanco Veterinary Vaccines Major Business
Table 7. Elanco Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. Elanco SWOT Analysis
Table 9. Elanco Veterinary Vaccines Product and Solutions
Table 10. Elanco Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. ARKO Labs Corporate Information, Location and Competitors
Table 12. ARKO Labs Veterinary Vaccines Major Business
Table 13. ARKO Labs Veterinary Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. ARKO Labs SWOT Analysis
Table 15. ARKO Labs Veterinary Vaccines Product and Solutions
Table 16. ARKO Labs Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Zoetis Corporate Information, Location and Competitors
Table 18. Zoetis Veterinary Vaccines Major Business
Table 19. Zoetis Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 20. Zoetis SWOT Analysis
Table 21. Zoetis Veterinary Vaccines Product and Solutions
Table 22. Zoetis Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Veterinary Vaccines Major Business
Table 25. Merck Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Veterinary Vaccines Product and Solutions
Table 28. Merck Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Aratana Therapeutics Corporate Information, Location and Competitors
Table 30. Aratana Therapeutics Veterinary Vaccines Major Business
Table 31. Aratana Therapeutics Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 32. Aratana Therapeutics SWOT Analysis
Table 33. Aratana Therapeutics Veterinary Vaccines Product and Solutions
Table 34. Aratana Therapeutics Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merial Corporate Information, Location and Competitors
Table 36. Merial Veterinary Vaccines Major Business
Table 37. Merial Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 38. Merial SWOT Analysis
Table 39. Merial Veterinary Vaccines Product and Solutions
Table 40. Merial Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. CanFel Therapeutics Corporate Information, Location and Competitors
Table 42. CanFel Therapeutics Veterinary Vaccines Major Business
Table 43. CanFel Therapeutics Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 44. CanFel Therapeutics SWOT Analysis
Table 45. CanFel Therapeutics Veterinary Vaccines Product and Solutions
Table 46. CanFel Therapeutics Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AmpliPhi Biosciences Corporate Information, Location and Competitors
Table 48. AmpliPhi Biosciences Veterinary Vaccines Major Business
Table 49. AmpliPhi Biosciences Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 50. AmpliPhi Biosciences SWOT Analysis
Table 51. AmpliPhi Biosciences Veterinary Vaccines Product and Solutions
Table 52. AmpliPhi Biosciences Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Advaxis Corporate Information, Location and Competitors
Table 54. Advaxis Veterinary Vaccines Major Business
Table 55. Advaxis Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 56. Advaxis SWOT Analysis
Table 57. Advaxis Veterinary Vaccines Product and Solutions
Table 58. Advaxis Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bayer Corporate Information, Location and Competitors
Table 60. Bayer Veterinary Vaccines Major Business
Table 61. Bayer Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 62. Bayer SWOT Analysis
Table 63. Bayer Veterinary Vaccines Product and Solutions
Table 64. Bayer Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Hygieia Biological Laboratories Corporate Information, Location and Competitors
Table 66. Hygieia Biological Laboratories Veterinary Vaccines Major Business
Table 67. Hygieia Biological Laboratories Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 68. Hygieia Biological Laboratories SWOT Analysis
Table 69. Hygieia Biological Laboratories Veterinary Vaccines Product and Solutions
Table 70. Hygieia Biological Laboratories Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Nuovo Biologics Corporate Information, Location and Competitors
Table 72. Nuovo Biologics Veterinary Vaccines Major Business
Table 73. Nuovo Biologics Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 74. Nuovo Biologics SWOT Analysis
Table 75. Nuovo Biologics Veterinary Vaccines Product and Solutions
Table 76. Nuovo Biologics Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Ceva Animal Health Corporate Information, Location and Competitors
Table 78. Ceva Animal Health Veterinary Vaccines Major Business
Table 79. Ceva Animal Health Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 80. Ceva Animal Health SWOT Analysis
Table 81. Ceva Animal Health Veterinary Vaccines Product and Solutions
Table 82. Ceva Animal Health Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Valneva Corporate Information, Location and Competitors
Table 84. Valneva Veterinary Vaccines Major Business
Table 85. Valneva Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 86. Valneva SWOT Analysis
Table 87. Valneva Veterinary Vaccines Product and Solutions
Table 88. Valneva Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. ImmuCell Corporate Information, Location and Competitors
Table 90. ImmuCell Veterinary Vaccines Major Business
Table 91. ImmuCell Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 92. ImmuCell SWOT Analysis
Table 93. ImmuCell Veterinary Vaccines Product and Solutions
Table 94. ImmuCell Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Genus Corporate Information, Location and Competitors
Table 96. Genus Veterinary Vaccines Major Business
Table 97. Genus Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 98. Genus SWOT Analysis
Table 99. Genus Veterinary Vaccines Product and Solutions
Table 100. Genus Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Colorado Serum Corporate Information, Location and Competitors
Table 102. Colorado Serum Veterinary Vaccines Major Business
Table 103. Colorado Serum Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 104. Colorado Serum SWOT Analysis
Table 105. Colorado Serum Veterinary Vaccines Product and Solutions
Table 106. Colorado Serum Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. UBI Veterinary Vaccines Type and Application
Table 108. UBI Veterinary Vaccines Major Business
Table 109. UBI Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 110. UBI SWOT Analysis
Table 111. UBI Veterinary Vaccines Product and Solutions
Table 112. UBI Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Nexvet Corporate Information, Location and Competitors
Table 114. Nexvet Veterinary Vaccines Major Business
Table 115. Nexvet Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 116. Nexvet SWOT Analysis
Table 117. Nexvet Veterinary Vaccines Product and Solutions
Table 118. Nexvet Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Epitopix Corporate Information, Location and Competitors
Table 120. Epitopix Veterinary Vaccines Major Business
Table 121. Epitopix Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 122. Epitopix SWOT Analysis
Table 123. Epitopix Veterinary Vaccines Product and Solutions
Table 124. Epitopix Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Vetoquinol Corporate Information, Location and Competitors
Table 126. Vetoquinol Veterinary Vaccines Major Business
Table 127. Vetoquinol Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 128. Vetoquinol SWOT Analysis
Table 129. Vetoquinol Veterinary Vaccines Product and Solutions
Table 130. Vetoquinol Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Virbac Corporate Information, Location and Competitors
Table 132. Virbac Veterinary Vaccines Major Business
Table 133. Virbac Veterinary Vaccines Total Revenue (USD Million) (2017-2018)
Table 134. Virbac SWOT Analysis
Table 135. Virbac Veterinary Vaccines Product and Solutions
Table 136. Virbac Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Global Veterinary Vaccines Revenue (Million USD) by Players (2015-2020)
Table 138. Global Veterinary Vaccines Revenue Share by Players (2015-2020)
Table 139. Global Veterinary Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 140. Global Veterinary Vaccines Revenue Market Share by Regions (2015-2020)
Table 141. North America Veterinary Vaccines Revenue by Countries (2015-2020)
Table 142. North America Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Table 143. Europe Veterinary Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 144. Asia-Pacific Veterinary Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 145. South America Veterinary Vaccines Revenue by Countries (2015-2020)
Table 146. South America Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Table 147. Middle East and Africa Veterinary Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 148. Middle East and Africa Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Table 149. Global Veterinary Vaccines Revenue (Million USD) by Type (2015-2020)
Table 150. Global Veterinary Vaccines Revenue Share by Type (2015-2020)
Table 151. Global Veterinary Vaccines Revenue Forecast by Type (2021-2025)
Table 152. Global Veterinary Vaccines Revenue by Application (2015-2020)
Table 153. Global Veterinary Vaccines Revenue Share by Application (2015-2020)
Table 154. Global Veterinary Vaccines Revenue Forecast by Application (2021-2025)
Table 155. Global Veterinary Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Veterinary Vaccines Picture
Figure 2. Global Veterinary Vaccines Revenue Market Share by Type in 2019
Figure 3. Inactivated Vaccines Picture
Figure 4. Live Attenuated Vaccines Picture
Figure 5. Conjugate Vaccines Picture
Figure 6. Toxoid Vaccines Picture
Figure 7. Recombinant Vaccines Picture
Figure 8. DNA Vaccines Picture
Figure 9. Veterinary Vaccines Revenue Market Share by Application in 2019
Figure 10. Veterinary Clinic Picture
Figure 11. Veterinary Hospital Picture
Figure 12. Veterinary Research Institute Picture
Figure 13. Retail Pharmacy Picture
Figure 14. Global Veterinary Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Veterinary Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Veterinary Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Veterinary Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Veterinary Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Veterinary Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Veterinary Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Veterinary Vaccines Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Veterinary Vaccines Revenue Market Share in 2019
Figure 23. Global Top 10 Players Veterinary Vaccines Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Veterinary Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Veterinary Vaccines Revenue Market Share by Regions (2015-2020)
Figure 27. Global Veterinary Vaccines Revenue Market Share by Regions in 2018
Figure 28. North America Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 29. Europe Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. South America Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 33. North America Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Figure 34. North America Veterinary Vaccines Revenue Market Share by Countries in 2019
Figure 35. USA Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. Canada Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 38. Europe Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Veterinary Vaccines Revenue Market Share by Countries in 2019
Figure 40. Germany Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 41. UK Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 42. France Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Russia Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Italy Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Veterinary Vaccines Revenue Market Share by Countries in 2019
Figure 47. China Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 48. Japan Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 49. Korea Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. India Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 52. South America Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Figure 53. South America Veterinary Vaccines Revenue Market Share by Countries in 2019
Figure 54. Brazil Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Veterinary Vaccines Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Veterinary Vaccines Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 59. UAE Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Veterinary Vaccines Revenue and Growth Rate (2015-2020)
Figure 62. Global Veterinary Vaccines Revenue Share by Type (2015-2020)
Figure 63. Global Veterinary Vaccines Revenue Share by Type in 2019
Figure 64. Global Veterinary Vaccines Market Share Forecast by Type (2021-2025)
Figure 65. Global Inactivated Vaccines Revenue Growth Rate (2015-2020)
Figure 66. Global Live Attenuated Vaccines Revenue Growth Rate (2015-2020)
Figure 67. Global Conjugate Vaccines Revenue Growth Rate (2015-2020)
Figure 68. Global Toxoid Vaccines Revenue Growth Rate (2015-2020)
Figure 69. Global Recombinant Vaccines Revenue Growth Rate (2015-2020)
Figure 70. Global DNA Vaccines Revenue Growth Rate (2015-2020)
Figure 71. Global Veterinary Vaccines Revenue Share by Application (2015-2020)
Figure 72. Global Veterinary Vaccines Revenue Share by Application in 2019
Figure 73. Global Veterinary Vaccines Market Share Forecast by Application (2021-2025)
Figure 74. Global Veterinary Clinic Revenue Growth Rate (2015-2020)
Figure 75. Global Veterinary Hospital Revenue Growth Rate (2015-2020)
Figure 76. Global Veterinary Research Institute Revenue Growth Rate (2015-2020)
Figure 77. Global Retail Pharmacy Revenue Growth Rate (2015-2020)
Figure 78. Global Veterinary Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Veterinary Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Veterinary Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Veterinary Vaccines Revenue Market Forecast (2021-2025)
Figure 82. Europe Veterinary Vaccines Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Veterinary Vaccines Revenue Market Forecast (2021-2025)
Figure 84. South America Veterinary Vaccines Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Veterinary Vaccines Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
